title: TLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice.
abstract: TLR9-deficient (TLR9⁻/⁻) NOD mice develop a significantly reduced incidence of diabetes. This study was to investigate the molecular mechanisms of the protective role of TLR9 deficiency. Through gene screening and confirmation by both mRNA and protein expression, we found a significant increase in CD73-expressing immune cells from peripheral lymphoid tissues in TLR9⁻/⁻ NOD mice. The elevated frequency of CD73-expressing immune cells seemed to be specific for TLR9 deficiency and was MyD88 independent. Moreover, the increased frequency of CD73 expression was limited to the NOD background. Increased frequency of CD73 expression was also associated with lower levels of proinflammatory cytokines and more anti-inflammatory cytokine production in CD4⁺ T cells in TLR9⁻/⁻ NOD mice. Purified CD73⁺CD4⁺ T cells showed stronger immunosuppressive function in vitro and delayed diabetes development in vivo. The immunosuppression appeared to be mediated by TGF-β. In addition, elevated frequency of CD73-expressing cells was associated with improved β cell function. Our observations were further confirmed by protection from diabetes with similar alterations in CD73 in the NY8.3 TCR NOD mouse model crossed with TLR9⁻/⁻ mice and by the use of a TLR9 inhibitor in NOD mice. Our novel findings suggest an important immune-regulatory role of CD73 in regulation of diabetes development and may offer a new therapeutic strategy for specific intervention to prevent type 1 diabetes.
authors: Section of Endocrinology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.
authors: Ningwen
authors: N
authors: Tai
authors: F Susan
authors: FS
authors: Wong
authors: Li
authors: L
authors: Wen
mesh_terms: D015720:5'-Nucleotidase / Q000096:biosynthesis* / Q000276:immunology; D019264:Adoptive Transfer; D000818:Animals; D002469:Cell Separation; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D005260:Female; D005434:Flow Cytometry; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D018345:Mice, Knockout; D060888:Real-Time Polymerase Chain Reaction; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D051217:Toll-Like Receptor 9 / Q000172:deficiency / Q000235:genetics / Q000276:immunology*
chemical_list: C495370:Tlr9 protein, mouse; D051217:Toll-Like Receptor 9; D015720:5'-Nucleotidase
references: Nature. 2000 Dec 7;408(6813):740-5
references: 11130078
references: Ann N Y Acad Sci. 2008 Dec;1150:187-9
references: 19120292
references: Annu Rev Pharmacol Toxicol. 2001;41:775-87
references: 11264476
references: J Autoimmun. 2007 Dec;29(4):310-8
references: 17959357
references: J Immunol. 2008 May 1;180(9):6288-96
references: 18424752
references: Acta Odontol Scand. 2001 Jun;59(3):124-30
references: 11501880
references: Curr Opin Crit Care. 2011 Oct;17(5):480-6
references: 21900767
references: Immunol Rev. 1998 Feb;161:95-109
references: 9553767
references: PLoS One. 2010 Jul 07;5(7):e11484
references: 20628601
references: J Exp Med. 2007 Jun 11;204(6):1257-65
references: 17502665
references: FASEB J. 2009 Feb;23(2):473-82
references: 18838482
references: Ann N Y Acad Sci. 2008 Dec;1150:146-8
references: 19120284
references: Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19857-62
references: 19073938
references: Nature. 2008 Oct 23;455(7216):1109-13
references: 18806780
references: J Clin Invest. 2002 Oct;110(7):993-1002
references: 12370277
references: J Immunol. 2008 Apr 1;180(7):4763-73
references: 18354200
references: Curr Opin Pharmacol. 2011 Aug;11(4):404-11
references: 21501972
references: Curr Opin Rheumatol. 2008 Sep;20(5):538-44
references: 18698174
references: Curr Mol Med. 2009 Feb;9(1):52-68
references: 19199942
references: Cell Signal. 2011 Nov;23(11):1869-75
references: 21756999
references: Indian Pediatr. 1994 Nov;31(11):1379-84
references: 7896337
references: J Immunol. 2002 Jan 1;168(1):348-55
references: 11751980
references: J Biol Chem. 2010 Mar 5;285(10):7176-86
references: 19858205
references: J Immunol. 2010 May 15;184(10):5645-53
references: 20393135
references: Res Immunol. 1997 Jun;148(5):327-32
references: 9352597
references: J Exp Med. 1997 Nov 17;186(10):1663-76
references: 9362527
references: J Immunol. 2001 Oct 1;167(7):3555-8
references: 11564765
references: Immunity. 2008 Oct 17;29(4):637-49
references: 18835196
references: Nature. 2003 Aug 14;424(6950):743-8
references: 12872135
references: Blood. 1996 Sep 1;88(5):1755-64
references: 8781432
references: FASEB J. 2008 Jul;22(7):2263-72
references: 18263696
references: Biochim Biophys Acta. 2008 May;1783(5):673-94
references: 18302942
references: Immunity. 1999 Oct;11(4):443-51
references: 10549626
references: J Immunol. 2006 Nov 15;177(10):6780-6
references: 17082591
references: Microbes Infect. 2003 May;5(6):515-26
references: 12758281
references: Methods Mol Biol. 2009;517:329-43
references: 19378024
references: Trends Immunol. 2001 Feb;22(2):78-83
references: 11286707
references: J Exp Med. 1998 Oct 19;188(8):1433-43
references: 9782120
references: J Leukoc Biol. 2002 Mar;71(3):538-44
references: 11867692
references: Annu Rev Immunol. 2005;23:447-85
references: 15771578
references: Science. 1998 Dec 11;282(5396):2085-8
references: 9851930
references: Am J Physiol Cell Physiol. 2011 Aug;301(2):C530-9
references: 21593451
references: Curr Pharm Des. 2010;16(9):1063-80
references: 20030612
references: Circ Res. 2008 Dec 5;103(12):1410-21
references: 19008478
references: Immunity. 1999 Jul;11(1):115-22
references: 10435584